• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Abstracts from the Journal of the American Geriatrics Society

  • Fri, 3/19/10 - 1:52pm
  • 0 Comments
  • 1782 reads
Citation: 

Pages 43 - 45

Training Nursing Staff to Recognize Depression in Home Healthcare
Ellen L. Brown, EdD, RN, Patrick J. Raue, PhD, Bernard A. Roos, MD, Thomas Sheeran, PhD, ME, and Martha L. Bruce, PhD, MPH

OBJECTIVES: To describe the implementation and acceptability of the TRaining In the Assessment of Depression (TRIAD) intervention, which has been tested in a randomized trial. The primary aim of TRIAD is to improve the ability of homecare nurses to detect depression in medically ill, older adult homecare patients.

DESIGN: Description of the important components of TRIAD, its implementation, and evaluation results from nurse surveys.

SETTING: Three certified home healthcare agencies in Westchester County, New York.

PARTICIPANTS: Thirty-six homecare nurses.

INTERVENTION: Participants randomly assigned to TRIAD (n=17) were provided with the opportunity to observe and practice patient interviewing. The approach focused on clinically meaningful identification of the two “gateway” symptoms of depression and is consistent with the newly revised Medicare mandatory Outcome and Assessment Information Set (OASIS-C). Control group participants (n=19) received no training beyond that which agencies may have provided routinely.

MEASUREMENTS: Baseline and 1-year nurse confidence in depression detection, and postintervention acceptability ratings of the TRIAD intervention.

RESULTS: Participants randomized to the TRIAD intervention reported a statistically significant increase in confidence in assessing for depression mood (P<.001), whereas the usual care group's confidence remained unchanged (P=.34) 1 year later.

CONCLUSION: An educational program designed to improve depression detection by giving nurses the skills and confidence to integrate depression assessment into the context of routine care can be successfully implemented with homecare agency support. The authors discuss the intervention in terms of OASIS-C and the “real world” realities of intervention implementation. J Am Geriatr Soc 2010;58(1):122-128.

Potentially Inappropriate Medications and Functional Decline in Elderly Hospitalized Patients
Andrea Corsonello, MD, Claudio Pedone, MD, Fabrizia Lattanzio, MD, Maria Lucchetti, ScD, Sabrina Garasto, ScD, Massimo Di Muzio, ScD, Sergio Giunta, MD, Graziano Onder, MD, Angelo Di Iorio, MD, Stefano Volpato, MD, Francesco Corica, MD, Chiara Mussi, MD, and Raffaele Antonelli Incalzi, MD on behalf of the Pharmacosur Veillance in the Elderly Care Study Group

OBJECTIVES: To verify whether the use of potentially inappropriate medications (PIMs) is associated with loss of independence in elderly in-patients by promoting adverse drug reactions (ADRs).

DESIGN: Prospective observational study.

PARTICIPANTS: Five hundred six patients aged 65 and older admitted to 11 acute care medical wards.

MEASUREMENTS: In-hospital loss of one or more activities of daily living (ADLs) and three or more ADLs. PIMs were identified according to diagnosis-independent Beers criteria and ascertained by study physicians based on daily review of medical and nurse records. The relationship between risk factors and outcomes was assessed using logistic regression.

RESULTS: Overall, 104 patients (20.6%) were taking at least one PIM at the time of admission (baseline users), and 49 (9.7%) were newly prescribed at least one PIM during their hospital stay. The loss of one or more ADLs occurred in 9.6% of baseline users, 16.3% of new users, and 8.5% of nonusers (P=.21) and that of three or more ADLs in 7.7% of baseline users, 12.2% of new users, and 4.8% of nonusers (P=.10). The lack of association was confirmed after correction for potential confounders, including ADRs.

image description image description
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

Getting the Most Out of Your Continuing Medical Education Classes

Neil Baum MD
2/8/12 | 0 Comments | 7 reads

February is American Heart Month

Alvin B Lin MD FAAFP
2/7/12 | 0 Comments | 26 reads

How to Create Collegiality in a Difference of Opinion: Part 2

Neil Baum MD
2/6/12 | 0 Comments | 36 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications